Darling Ingredients insider plans Rule 144 stock sale

Darling Ingredients Inc. is the issuer for a planned stock sale under Rule 144.

Rhea-AI Filing Summary

Darling Ingredients Inc. is the issuer for a planned stock sale under Rule 144. A holder intends to sell 100,000 shares of common stock through J.P. Morgan Securities LLC on the NYSE, with an aggregate market value of $5,031,000.

The securities were originally acquired from the issuer on 01/15/2021 as compensation, and the approximate sale date indicated is 02/13/2026. The filing notes that the seller represents not knowing any undisclosed material adverse information about Darling Ingredients’ current or prospective operations.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does Darling Ingredients (DAR) report in this Form 144 filing?

The filing reports a planned sale of 100,000 Darling Ingredients common shares under Rule 144. The shares were acquired as compensation in January 2021 and are expected to be sold on the NYSE through J.P. Morgan Securities LLC.

How many Darling Ingredients (DAR) shares are planned to be sold and at what value?

The holder plans to sell 100,000 shares of Darling Ingredients common stock, with an aggregate market value of $5,031,000. This amount is based on the market price used in the Rule 144 notice at the time of filing.

When were the Darling Ingredients (DAR) shares being sold under Rule 144 originally acquired?

The 100,000 Darling Ingredients shares were acquired on 01/15/2021 as compensation from the issuer. The same date is listed as the payment date, indicating the award and acquisition occurred simultaneously as part of a compensation transaction.

When is the planned sale date for the Darling Ingredients (DAR) shares under this Form 144?

The notice lists an approximate sale date of 02/13/2026 for the 100,000 Darling Ingredients common shares. This is an anticipated date for the transaction, as Form 144 discloses proposed, rather than completed, sales.

On which exchange and through which broker will the Darling Ingredients (DAR) shares be sold?

The filing states the 100,000 Darling Ingredients common shares are to be sold on the NYSE. J.P. Morgan Securities LLC, based at 270 Madison Avenue in New York, is identified as the broker handling the planned transaction.

How many Darling Ingredients (DAR) shares are outstanding according to this Form 144?

The notice lists 158,186,082 Darling Ingredients common shares outstanding. This figure provides context for the planned 100,000-share sale under Rule 144, showing the overall size of the company’s equity base at the time of the filing.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 02/13/2026 - 04:00 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001098932
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Darling Ingredients, Inc.
SEC File Number	001-13323
Address of Issuer	5601 N. MacArthur Blvd Irving TEXAS 75038
Phone	972-717-0300
Name of Person for Whose Account the Securities are To Be Sold	John Sterling
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Former General Counsel

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common Stock	J.P. Morgan Securities LLC 270 Madison Avenue - 10th Floor New York NY 10017	100000	5031000	158186082	02/13/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common Stock	01/15/2021	Compensation	Issuer			100000	01/15/2021	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks	The securities to be sold were acquired via the vesting of Restricted Stock Units, Performance Stock Units and Stock Option exercises during the period of 01/15/2021 through 01/03/2025.
Date of Notice	02/13/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ J.P. Morgan Securities LLC as agent and attorney-in-fact for John Sterling
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)